Synthetics Biologics, Inc. (NYSEMKT:SYN) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $0.87, up from yesterday’s close by -0.43%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.
No amount of research is complete without a bird’s eye view of the financial data. Synthetics Biologics, Inc. (SYN) currently trades with a market capitalization of $101.49M.
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For SYN, the company currently has $4.55M of cash on the books, which is offset by $0.00 current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $-17.38M over the past twelve months. Generally speaking, earnings are expected to fall in coming quarters. Analysts are forecasting earnings of 0.21 on a per share basis this quarter. Perhaps, that suggests something about why 25.50% of the outstanding share supply is held by institutional investors.
It’s important to check the technicals to get a sense of how has been acting. Looking at the stock’s movement on the chart, Synthetics Biologics, Inc. recorded a 52-week high of 2.74. It is now trading 1.87 off that level. The stock is trading 0.84 its 50-day moving average by -0.03. The stock carved out a 52-week low down at 0.73.
In recent action, Synthetics Biologics, Inc. (SYN) has made a move of +2.35% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 65.98, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 66.26M with 13.44% sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of SYN.